Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 16/20 | 0.45 |
| ▸ | CA2 | P00918 | 16/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | STS | P08842 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 2/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27677621 | 0.79 | THRB (0.46) | CA1CA2THRBSTSF2 | |
| SCHEMBL28064218 | 0.78 | THRB (0.45) | CA1CA2THRBSTSF2 | |
| SCHEMBL27712919 | 0.78 | THRB (0.45) | CA1CA2THRBSTSF2 | |
| Potassium Ion SCHEMBL27498497 | 0.76 | THRB (0.43) | CA1CA2THRBF2PRSS1 | |
| SCHEMBL22322503 | 0.76 | THRB (0.43) | CA1CA2THRBF2PRSS1 | |
| SCHEMBL29066797 | 0.76 | THRB (0.43) | CA1CA2THRBF2PRSS1 | |
| SCHEMBL27641982 | 0.76 | THRB (0.43) | CA1CA2THRBF2PRSS1 | |
| SCHEMBL7182154 | 0.75 | CA1 (0.37) | CA1CA2 | |
| SCHEMBL16505929 | 0.75 | THRB (0.42) | CA1CA2THRBF2PRSS1 | |
| SCHEMBL11743004 | 0.72 | CA1 (0.33) | CA1CA2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6583130-B1 | Substituted with acyl, oxycarbonyl, aminocarbonyl, sulfonyl, or aminosulfonyl; inhibit steroid sulfatase, do not exhibit any estrogenic effect and will not yield any estrogenic products on hydrolysis; treatment of estrogen-dependent tumors | SCHERING AG (DE) | 2003-06-24 | — | — | US | claimed |
| US-6583130-B1 | Substituted with acyl, oxycarbonyl, aminocarbonyl, sulfonyl, or aminosulfonyl; inhibit steroid sulfatase, do not exhibit any estrogenic effect and will not yield any estrogenic products on hydrolysis; treatment of estrogen-dependent tumors | SCHERING AG (DE) | 2003-06-24 | — | — | US | disclosed |